Clinical Trials · NCT00227773
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
- Phase
- Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- Eastern Cooperative Oncology Group
- Enrollment
- 0
- Start date
- Not specified
- Locations
- See registry
- Primary endpoint
- Study in Gastrointestinal Carcinoid Tumor